Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.02 USD | -0.42% | +0.23% | -6.27% |
05-31 | Piper Sandler Starts Arcellx With Overweight Rating, $70 Price Target | MT |
05-15 | Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.78B | - | |||||
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |
- Stock Market
- Equities
- ACLX Stock
- Charts Arcellx, Inc.
- Sector Chart